Israeli startup GrayMatters treats PTSD with avatars
GrayMatters received US FDA approval for marketing its technology in March and after the start of the Israel-Hamas war received approval in Israel.
Stay updated with breaking news from Joy Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GrayMatters received US FDA approval for marketing its technology in March and after the start of the Israel-Hamas war received approval in Israel.
Corundum Neuroscience aunches a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation.
- Jim Schuermann, president and CEO of Saluda Medical, will deliver the keynote address -
ENewsChannels NEWS: -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that several promising neurotechnology startups and early-stage firms will present at the 2023 Neurotech Leaders Forum in San Francisco, November 6-7. The 23rd annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry. :: News from eNewsChannels
The Ghana Revenue Authority (GRA) compliance and enforcement unit has closed down four businesses for failure to issue Value...